nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—ADRA1B—vas deferens—urinary bladder cancer	0.207	0.561	CbGeAlD
Alfuzosin—Prazosin—MT3—urinary bladder cancer	0.0324	1	CrCbGaD
Alfuzosin—ADRA1D—prostate gland—urinary bladder cancer	0.0181	0.049	CbGeAlD
Alfuzosin—CYP3A4—urine—urinary bladder cancer	0.0173	0.047	CbGeAlD
Alfuzosin—ADRA1D—epithelium—urinary bladder cancer	0.0133	0.036	CbGeAlD
Alfuzosin—ADRA1B—renal system—urinary bladder cancer	0.0126	0.0342	CbGeAlD
Alfuzosin—ADRA1D—urethra—urinary bladder cancer	0.0121	0.0328	CbGeAlD
Alfuzosin—ADRA1A—prostate gland—urinary bladder cancer	0.0104	0.0282	CbGeAlD
Alfuzosin—KCNH2—prostate gland—urinary bladder cancer	0.01	0.0272	CbGeAlD
Alfuzosin—ADRA1D—female reproductive system—urinary bladder cancer	0.00985	0.0268	CbGeAlD
Alfuzosin—KCNH2—seminal vesicle—urinary bladder cancer	0.00847	0.023	CbGeAlD
Alfuzosin—ADRA1A—epithelium—urinary bladder cancer	0.00762	0.0207	CbGeAlD
Alfuzosin—ADRA1A—renal system—urinary bladder cancer	0.00707	0.0192	CbGeAlD
Alfuzosin—KCNH2—renal system—urinary bladder cancer	0.00683	0.0185	CbGeAlD
Alfuzosin—KCNH2—urethra—urinary bladder cancer	0.0067	0.0182	CbGeAlD
Alfuzosin—KCNH2—female reproductive system—urinary bladder cancer	0.00547	0.0149	CbGeAlD
Alfuzosin—KCNH2—vagina—urinary bladder cancer	0.00494	0.0134	CbGeAlD
Alfuzosin—CYP3A4—renal system—urinary bladder cancer	0.00423	0.0115	CbGeAlD
Alfuzosin—CYP3A4—female reproductive system—urinary bladder cancer	0.00339	0.0092	CbGeAlD
Alfuzosin—KCNH2—lymph node—urinary bladder cancer	0.0032	0.00869	CbGeAlD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00115	0.00192	CcSEcCtD
Alfuzosin—Somnolence—Fluorouracil—urinary bladder cancer	0.00115	0.00192	CcSEcCtD
Alfuzosin—Hypotension—Cisplatin—urinary bladder cancer	0.00114	0.00191	CcSEcCtD
Alfuzosin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00114	0.0019	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00113	0.00189	CcSEcCtD
Alfuzosin—Fatigue—Gemcitabine—urinary bladder cancer	0.00113	0.00189	CcSEcCtD
Alfuzosin—Pain—Gemcitabine—urinary bladder cancer	0.00112	0.00187	CcSEcCtD
Alfuzosin—Constipation—Gemcitabine—urinary bladder cancer	0.00112	0.00187	CcSEcCtD
Alfuzosin—Asthenia—Thiotepa—urinary bladder cancer	0.00112	0.00187	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00112	0.00186	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00112	0.00186	CcSEcCtD
Alfuzosin—Infection—Etoposide—urinary bladder cancer	0.00111	0.00186	CcSEcCtD
Alfuzosin—Pruritus—Thiotepa—urinary bladder cancer	0.00111	0.00184	CcSEcCtD
Alfuzosin—Pain—Fluorouracil—urinary bladder cancer	0.0011	0.00184	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.0011	0.00183	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.0011	0.00183	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—urinary bladder cancer	0.0011	0.00183	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—urinary bladder cancer	0.00109	0.00182	CcSEcCtD
Alfuzosin—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00109	0.00182	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00108	0.00181	CcSEcCtD
Alfuzosin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00108	0.00181	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00108	0.0018	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00108	0.0018	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—urinary bladder cancer	0.00108	0.0018	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—urinary bladder cancer	0.00107	0.00178	CcSEcCtD
Alfuzosin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00107	0.00178	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00107	0.00178	CcSEcCtD
Alfuzosin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00106	0.00178	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—urinary bladder cancer	0.00106	0.00177	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00106	0.00176	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—urinary bladder cancer	0.00105	0.00176	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—urinary bladder cancer	0.00105	0.00176	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—urinary bladder cancer	0.00105	0.00176	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—urinary bladder cancer	0.00105	0.00175	CcSEcCtD
Alfuzosin—Pain—Cisplatin—urinary bladder cancer	0.00105	0.00175	CcSEcCtD
Alfuzosin—Dizziness—Thiotepa—urinary bladder cancer	0.00103	0.00172	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00103	0.00171	CcSEcCtD
Alfuzosin—Urticaria—Fluorouracil—urinary bladder cancer	0.00103	0.00171	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—urinary bladder cancer	0.00101	0.00169	CcSEcCtD
Alfuzosin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00101	0.00168	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—urinary bladder cancer	0.000997	0.00166	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000997	0.00166	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000997	0.00166	CcSEcCtD
Alfuzosin—Vomiting—Thiotepa—urinary bladder cancer	0.000993	0.00166	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—urinary bladder cancer	0.000986	0.00164	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—urinary bladder cancer	0.000986	0.00164	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000986	0.00164	CcSEcCtD
Alfuzosin—Rash—Thiotepa—urinary bladder cancer	0.000985	0.00164	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—urinary bladder cancer	0.000984	0.00164	CcSEcCtD
Alfuzosin—Dermatitis—Thiotepa—urinary bladder cancer	0.000984	0.00164	CcSEcCtD
Alfuzosin—Headache—Thiotepa—urinary bladder cancer	0.000979	0.00163	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000969	0.00162	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—urinary bladder cancer	0.000967	0.00161	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000967	0.00161	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—urinary bladder cancer	0.000961	0.0016	CcSEcCtD
Alfuzosin—Constipation—Etoposide—urinary bladder cancer	0.000959	0.0016	CcSEcCtD
Alfuzosin—Pain—Etoposide—urinary bladder cancer	0.000959	0.0016	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000951	0.00159	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—urinary bladder cancer	0.000945	0.00158	CcSEcCtD
Alfuzosin—Asthenia—Gemcitabine—urinary bladder cancer	0.000943	0.00157	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000939	0.00157	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000934	0.00156	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000933	0.00156	CcSEcCtD
Alfuzosin—Pruritus—Gemcitabine—urinary bladder cancer	0.00093	0.00155	CcSEcCtD
Alfuzosin—Nausea—Thiotepa—urinary bladder cancer	0.000928	0.00155	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—urinary bladder cancer	0.000927	0.00155	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—urinary bladder cancer	0.000925	0.00154	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000925	0.00154	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000917	0.00153	CcSEcCtD
Alfuzosin—Pruritus—Fluorouracil—urinary bladder cancer	0.000914	0.00152	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000912	0.00152	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—urinary bladder cancer	0.000912	0.00152	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000912	0.00152	CcSEcCtD
Alfuzosin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000899	0.0015	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000894	0.00149	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—urinary bladder cancer	0.000891	0.00149	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—urinary bladder cancer	0.000889	0.00148	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—urinary bladder cancer	0.000888	0.00148	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—urinary bladder cancer	0.000887	0.00148	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—urinary bladder cancer	0.000884	0.00147	CcSEcCtD
Alfuzosin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000884	0.00147	CcSEcCtD
Alfuzosin—Asthenia—Cisplatin—urinary bladder cancer	0.000879	0.00147	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000879	0.00147	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000878	0.00146	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—urinary bladder cancer	0.000875	0.00146	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000874	0.00146	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00087	0.00145	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000868	0.00145	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000863	0.00144	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—urinary bladder cancer	0.000858	0.00143	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000856	0.00143	CcSEcCtD
Alfuzosin—Dizziness—Fluorouracil—urinary bladder cancer	0.000854	0.00143	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000853	0.00142	CcSEcCtD
Alfuzosin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000838	0.0014	CcSEcCtD
Alfuzosin—Vomiting—Gemcitabine—urinary bladder cancer	0.000835	0.00139	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—urinary bladder cancer	0.000829	0.00138	CcSEcCtD
Alfuzosin—Rash—Gemcitabine—urinary bladder cancer	0.000828	0.00138	CcSEcCtD
Alfuzosin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000828	0.00138	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—urinary bladder cancer	0.000827	0.00138	CcSEcCtD
Alfuzosin—Headache—Gemcitabine—urinary bladder cancer	0.000823	0.00137	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—urinary bladder cancer	0.000822	0.00137	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000822	0.00137	CcSEcCtD
Alfuzosin—Vomiting—Fluorouracil—urinary bladder cancer	0.000821	0.00137	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000821	0.00137	CcSEcCtD
Alfuzosin—Rash—Fluorouracil—urinary bladder cancer	0.000815	0.00136	CcSEcCtD
Alfuzosin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000814	0.00136	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000813	0.00136	CcSEcCtD
Alfuzosin—Headache—Fluorouracil—urinary bladder cancer	0.000809	0.00135	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000809	0.00135	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—urinary bladder cancer	0.000805	0.00134	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000805	0.00134	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—urinary bladder cancer	0.000803	0.00134	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000803	0.00134	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000798	0.00133	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—urinary bladder cancer	0.000797	0.00133	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—urinary bladder cancer	0.000794	0.00132	CcSEcCtD
Alfuzosin—Nausea—Gemcitabine—urinary bladder cancer	0.00078	0.0013	CcSEcCtD
Alfuzosin—Vomiting—Cisplatin—urinary bladder cancer	0.000779	0.0013	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—urinary bladder cancer	0.000776	0.00129	CcSEcCtD
Alfuzosin—Rash—Cisplatin—urinary bladder cancer	0.000772	0.00129	CcSEcCtD
Alfuzosin—Dermatitis—Cisplatin—urinary bladder cancer	0.000772	0.00129	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—urinary bladder cancer	0.000768	0.00128	CcSEcCtD
Alfuzosin—Nausea—Fluorouracil—urinary bladder cancer	0.000767	0.00128	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000765	0.00128	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000764	0.00127	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00076	0.00127	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—urinary bladder cancer	0.00076	0.00127	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—urinary bladder cancer	0.000745	0.00124	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000743	0.00124	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—urinary bladder cancer	0.000743	0.00124	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—urinary bladder cancer	0.000742	0.00124	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—urinary bladder cancer	0.00074	0.00123	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000738	0.00123	CcSEcCtD
Alfuzosin—Nausea—Cisplatin—urinary bladder cancer	0.000727	0.00121	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000718	0.0012	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000715	0.00119	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—urinary bladder cancer	0.000713	0.00119	CcSEcCtD
Alfuzosin—Rash—Etoposide—urinary bladder cancer	0.000707	0.00118	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—urinary bladder cancer	0.000707	0.00118	CcSEcCtD
Alfuzosin—Headache—Etoposide—urinary bladder cancer	0.000703	0.00117	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—urinary bladder cancer	0.000701	0.00117	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—urinary bladder cancer	0.000701	0.00117	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000696	0.00116	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—urinary bladder cancer	0.000695	0.00116	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—urinary bladder cancer	0.000693	0.00116	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—urinary bladder cancer	0.000692	0.00115	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—urinary bladder cancer	0.000691	0.00115	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—urinary bladder cancer	0.00069	0.00115	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—urinary bladder cancer	0.000681	0.00114	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000677	0.00113	CcSEcCtD
Alfuzosin—Infection—Methotrexate—urinary bladder cancer	0.000668	0.00111	CcSEcCtD
Alfuzosin—Nausea—Etoposide—urinary bladder cancer	0.000666	0.00111	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000662	0.0011	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000659	0.0011	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000658	0.0011	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—urinary bladder cancer	0.000656	0.00109	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—urinary bladder cancer	0.000656	0.00109	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—urinary bladder cancer	0.000653	0.00109	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000652	0.00109	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00065	0.00108	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—urinary bladder cancer	0.000648	0.00108	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—urinary bladder cancer	0.000643	0.00107	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—urinary bladder cancer	0.000642	0.00107	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—urinary bladder cancer	0.000641	0.00107	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—urinary bladder cancer	0.000639	0.00107	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—urinary bladder cancer	0.00063	0.00105	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—urinary bladder cancer	0.000629	0.00105	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—urinary bladder cancer	0.000628	0.00105	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000627	0.00105	CcSEcCtD
Alfuzosin—Infection—Epirubicin—urinary bladder cancer	0.000625	0.00104	CcSEcCtD
Alfuzosin—Shock—Epirubicin—urinary bladder cancer	0.000619	0.00103	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000617	0.00103	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000616	0.00103	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—urinary bladder cancer	0.000614	0.00102	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000612	0.00102	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—urinary bladder cancer	0.000611	0.00102	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000608	0.00101	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000607	0.00101	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—urinary bladder cancer	0.000607	0.00101	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000603	0.00101	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—urinary bladder cancer	0.0006	0.001	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—urinary bladder cancer	0.000597	0.000997	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000594	0.00099	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000592	0.000987	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—urinary bladder cancer	0.000588	0.00098	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—urinary bladder cancer	0.000582	0.000971	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00058	0.000968	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—urinary bladder cancer	0.000579	0.000967	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—urinary bladder cancer	0.000578	0.000964	CcSEcCtD
Alfuzosin—Pain—Methotrexate—urinary bladder cancer	0.000575	0.000959	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000573	0.000956	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—urinary bladder cancer	0.000573	0.000955	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000571	0.000952	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00057	0.00095	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000568	0.000947	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000565	0.000943	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000563	0.000938	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—urinary bladder cancer	0.000559	0.000933	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000554	0.000924	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000554	0.000923	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00055	0.000917	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—urinary bladder cancer	0.000544	0.000907	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000543	0.000906	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—urinary bladder cancer	0.000542	0.000904	CcSEcCtD
Alfuzosin—Pain—Epirubicin—urinary bladder cancer	0.000538	0.000897	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—urinary bladder cancer	0.000538	0.000897	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—urinary bladder cancer	0.000534	0.000891	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000531	0.000886	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00053	0.000884	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000518	0.000865	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—urinary bladder cancer	0.000517	0.000863	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000514	0.000858	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000512	0.000854	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000502	0.000838	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—urinary bladder cancer	0.000502	0.000837	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—urinary bladder cancer	0.0005	0.000833	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—urinary bladder cancer	0.000498	0.00083	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—urinary bladder cancer	0.000498	0.00083	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000497	0.000829	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—urinary bladder cancer	0.000482	0.000804	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00048	0.0008	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000476	0.000794	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—urinary bladder cancer	0.000475	0.000793	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—urinary bladder cancer	0.000462	0.000771	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00046	0.000767	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00046	0.000767	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—urinary bladder cancer	0.000451	0.000753	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—urinary bladder cancer	0.000445	0.000742	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—urinary bladder cancer	0.000444	0.000741	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—urinary bladder cancer	0.00043	0.000718	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—urinary bladder cancer	0.000427	0.000713	CcSEcCtD
Alfuzosin—Rash—Methotrexate—urinary bladder cancer	0.000424	0.000707	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—urinary bladder cancer	0.000423	0.000706	CcSEcCtD
Alfuzosin—Headache—Methotrexate—urinary bladder cancer	0.000421	0.000702	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—urinary bladder cancer	0.000418	0.000696	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—urinary bladder cancer	0.000416	0.000694	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—urinary bladder cancer	0.000412	0.000687	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—urinary bladder cancer	0.0004	0.000667	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—urinary bladder cancer	0.000399	0.000666	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000398	0.000664	CcSEcCtD
Alfuzosin—Rash—Epirubicin—urinary bladder cancer	0.000397	0.000661	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—urinary bladder cancer	0.000396	0.000661	CcSEcCtD
Alfuzosin—Headache—Epirubicin—urinary bladder cancer	0.000394	0.000657	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—urinary bladder cancer	0.000385	0.000642	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—urinary bladder cancer	0.000374	0.000623	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—urinary bladder cancer	0.00037	0.000617	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—urinary bladder cancer	0.000367	0.000612	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000367	0.000611	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—urinary bladder cancer	0.000365	0.000608	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—urinary bladder cancer	0.000346	0.000577	CcSEcCtD
